Optinose to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference

YARDLEY, Pa., June 20, 2019 (GLOBE NEWSWIRE) -- Optinose (OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter Miller will present at the 2019 BMO Capital Markets Prescriptions for Success Healthcare Conference on June 25, 2019, at 9:40 a.m. ET.

To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.

A replay of the webcast will be available for 30 days following the conclusion of the event.

About Optinose
Optinose is a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. Optinose has offices in the U.S., the U.K. and Norway. To learn more, please visit www.optinose.com or follow us on Twitter$(TWTR)$ and LinkedIn.  

Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。
登录后可参与评论
小虎正在努力加载中~

推荐内容

小虎正在努力加载中~